Avista Capital Partners ("Avista") and Nordic Capital are jointly launching a public tender offer to acquire all outstanding shares of Acino Holding AG ("Acino"), a Swiss based leader in advanced drug delivery technologies listed on the SIX Swiss Exchange. Avista and Nordic Capital offer CHF 115 per Acino share representing a total equity value of approximately CHF 400 million. The board of directors of Acino recommends to its shareholders the acceptance of the offer. The transaction is considered to be the first Private Equity led public to private transaction in Switzerland.
Bär & Karrer advises Acino in this transaction. The team includes Thomas Reutter, Mariel Hoch, Daniel Raun, Daniel Heiniger, Annette Weber (Corporate), Mani Reinert and Romina Brogini (Antitrust) as well as Raoul Stocker and Michael Barrot (Tax).